Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs - Xu, Q; Zhou, F; Liu, H (J Thorac Oncol, 2018)
et al.